The Carle Cancer Center CCOP, Urbana, IL. is applying to continue to be designated as a CCOP in East Central Illinois. As the 12th largest private medical practice group in the United States, the Carle Clinic Association has a fully developed Community Cancer Center program. The Carle Clinic is one of Illinois' largest down-state referring centers for all forms of medical care seeing over 450,000 patients annually throughout our system. Since 1976 the Carle Clinic has been an active participant in the Cancer Control Program of the Eastern Cooperative Oncology Group (ECOG) registering 233 patients on national protocols prior to becoming a CCOP award institution in 1983. From 1983 to date we have registered 182 additional patients on study for an average of 61 patients per year. In making this application for a continuation of our CCOP award, the Carle Cancer Center, composed of five hematologists/oncologists and a radiation therapist, states that it will register at least 88 patients on ECOG protocols and 21 patients per year on the protocols of Illinois Cancer Council (the comprehensive cancer center for the State of Illinois). To accomplish this we will have two affiliates in our program consisting of the Carbondale Clinic of Carbondale IL and the Danville Veterans Administration Medical Center of Danville, IL. The Danville VA is staffed by physicians from the Carle Cancer Center. The Carbondale Clinic is a 34 member multispecialty clinic located in Carbondale Illinois in the southern portion of this state. In addition to increasing the Cancer Center's accrual to therapeutic protocols the CCOP will also participate in Cancer Control research through the research bases offered by ECOG, the Illinois Cancer Council, and the Fox Chase Cancer Center. If granted this award the Carle Cancer Center and its affiliates will endeavor to facilitate transfer of modern methods of cancer treatment and cancer control technology to the citizens and health professionals of our region. It is our continued belief that a cancer center should participate in clinical research protocols, public and professional education, and cancer prevention and detection as well as provide the highest standards of clinical cancer care.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA035195-05
Application #
3557614
Study Section
(SRC)
Project Start
1983-09-15
Project End
1990-05-31
Budget Start
1988-06-01
Budget End
1989-05-31
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Carle Clinic Association, P C
Department
Type
DUNS #
075606517
City
Urbana
State
IL
Country
United States
Zip Code
61801
Liu, Xiaonan; Li, Jing; Schild, Steven E et al. (2017) Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy. J Cancer Ther 8:73-85
Sio, Terence T; Atherton, Pamela J; Birckhead, Brandon J et al. (2016) Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]). Support Care Cancer 24:3847-55
Liu, Xiaonan; Li, Jing; Wu, Teresa et al. (2016) Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ? 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers. OMICS J Radiol 5:
Zhao, Yujie; Foster, Nathan R; Meyers, Jeffrey P et al. (2015) A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321. J Thorac Oncol 10:172-80
Park, Haeseong; Qin, Rui; Smith, Thomas J et al. (2015) North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause 22:627-32
Van Loon, Katherine; Espinoza, Anne M; Fogelman, David R et al. (2014) Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab. Pancreas 43:343-9
Dronca, Roxana S; Allred, Jacob B; Perez, Domingo G et al. (2014) Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675. Am J Clin Oncol 37:369-76
Barton, Debra L; Thanarajasingam, Gita; Sloan, Jeff A et al. (2014) Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance). Cancer 120:3575-83
Leal, Alexis D; Qin, Rui; Atherton, Pamela J et al. (2014) North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study. Cancer 120:1890-7
Province, M A; Goetz, M P; Brauch, H et al. (2014) CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clin Pharmacol Ther 95:216-27

Showing the most recent 10 out of 164 publications